V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10260817 | 10038071 | 0 | 81.6 | Palliative (P) | 2018-09-06 | 2018-10-10 | Cisplatin | N | N | CISPLATIN | 101021883 |
| 10260885 | 10038074 | 1.71 | 62.8 | Disease modification (D) | null | 2022-05-06 | null | null | null | CAPECITABINE + MITOMYCIN | 101087832 |
| 10260903 | 10038075 | null | 68.8 | Palliative (P) | null | 2018-05-21 | null | null | N | FLUOROURACIL + MITOMYCIN | 101188771 |
| 10260919 | 10038078 | 1.7 | 84.4 | Curative (C) | null | 2019-06-27 | null | null | null | CARBOPLATIN + GEMCITABINE | 100269918 |
| 10260922 | 10038079 | 1.75 | 85 | Palliative (P) | null | 2017-10-10 | null | null | N | PACLITAXEL | 101869660 |
| 10261012 | 10038082 | 1.71 | 0 | Curative (C) | null | 2017-07-29 | null | null | null | PACLITAXEL | 100636378 |
| 10261092 | 10038085 | null | 84.1 | null | 2020-02-03 | 2020-02-03 | GEMCITABINE | 02 | null | GEMCITABINE | 100927112 |
| 10261106 | 10038086 | 1.72 | 66 | Adjuvant (A) | null | 2017-03-08 | null | null | N | FLUOROURACIL + OXALIPLATIN | 100911069 |
| 10261150 | 10038087 | 1.73 | 79.1 | 03 | null | 2019-10-16 | null | null | N | TRIAL UNSPECIFIED | 101026328 |
| 10261152 | 10038088 | 1.68 | 67.2 | null | null | 2018-05-16 | null | null | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100289638 |
| 10261188 | 10038089 | 1.81 | 71.9 | null | 2019-03-12 | 2019-03-16 | Carboplatin + Pemetrexed | 02 | null | CARBOPLATIN + PEMETREXED | 100399349 |
| 10261256 | 10038092 | 1.72 | null | Adjuvant (A) | null | 2019-06-03 | null | null | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100767062 |
| 10261328 | 10038093 | 1.57 | null | null | null | 2019-03-23 | null | null | null | IMATINIB | 100576711 |
| 10261350 | 10038094 | 1.87 | 93.4 | null | null | 2017-02-13 | null | null | null | CISPLATIN + GEMCITABINE | 101300976 |
| 10261377 | 10038096 | 1.57 | 47.8 | null | null | 2019-03-01 | null | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100701128 |
| 10261386 | 10038097 | 1.75 | 96.8 | null | null | 2019-08-06 | null | null | N | CISPLATIN + GEMCITABINE | 101078179 |
| 10261462 | 10038098 | null | 86.35 | Curative (C) | null | 2020-02-14 | null | null | N | FLUOROURACIL + MITOMYCIN | 100952307 |
| 10261468 | 10038099 | 1.87 | 0 | Curative (C) | null | 2019-08-20 | null | null | null | IMATINIB | 101210822 |
| 10261527 | 10038101 | 1.83 | 0 | Curative (C) | null | 2018-10-26 | null | null | Y | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101236771 |
| 10261555 | 10038102 | 1.7 | 0 | Palliative (P) | 2018-06-25 | 2018-06-26 | Cisplatin | 02 | null | CISPLATIN | 100343760 |
| 10261611 | 10038104 | 1.71 | 97.2 | 03 | null | 2017-11-25 | null | null | null | CISPLATIN | 101239525 |
| 10261636 | 10038105 | 1.69 | 77.2 | Palliative (P) | null | 2019-03-01 | null | null | N | TRIAL UNSPECIFIED | 101725326 |
| 10261652 | 10038106 | 1.81 | 60.8 | 03 | 2018-06-13 | 2018-06-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101199699 |
| 10261695 | 10038107 | 1.53 | 91 | Palliative (P) | null | 2019-06-15 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100357613 |
| 10261743 | 10038108 | 1.62 | 55 | null | 2020-11-06 | 2020-11-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101023007 |
| 10261763 | 10038109 | 1.6 | 44 | null | null | 2019-06-03 | null | null | null | CHLORAMBUCIL | 101782227 |
| 10261770 | 10038110 | 1.73 | 72 | Adjuvant (A) | 2017-02-21 | 2017-03-04 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100023731 |
| 10261823 | 10038112 | 1.64 | 76.6 | Palliative (P) | 2016-02-09 | 2016-02-17 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100602869 |
| 10261830 | 10038113 | 1.58 | 66.5 | Palliative (P) | null | 2017-07-31 | null | null | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101479438 |
| 10261887 | 10038115 | 1.73 | 66.8 | 03 | null | 2017-11-27 | null | null | N | TRIAL UNSPECIFIED | 101471023 |
| 10261938 | 10038117 | 1.68 | 71.65 | Palliative (P) | null | 2017-12-30 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100770714 |
| 10261943 | 10038118 | 1.69 | 78.75 | Palliative (P) | null | 2016-05-09 | null | null | Y | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100917521 |
| 10261969 | 10038120 | null | 45.9 | Palliative (P) | null | 2019-10-14 | null | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100343665 |
| 10261980 | 10038121 | 1.78 | 109 | Palliative (P) | null | 2018-08-15 | null | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100759187 |
| 10261989 | 10038122 | 1.64 | 73.2 | 03 | null | 2019-06-15 | null | null | N | CARBOPLATIN + GEMCITABINE | 100726883 |
| 10262060 | 10038123 | 1.77 | 101 | Palliative (P) | 2019-07-21 | 2019-07-28 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100530453 |
| 10262179 | 10038125 | 1.53 | 41.45 | Curative (C) | 2016-07-25 | 2016-08-07 | Carboplatin + Pemetrexed | N | null | CARBOPLATIN + PEMETREXED | 100950647 |
| 10262269 | 10038127 | 1.56 | 80 | null | 2021-04-29 | 2021-05-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 100634888 |
| 10262301 | 10038128 | 1.72 | 73.1 | Neo-adjuvant (N) | 2018-09-23 | 2018-10-13 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101797923 |
| 10262352 | 10038131 | 1.55 | 74.3 | null | null | 2019-03-20 | null | null | null | CAPECITABINE + MITOMYCIN | 100362035 |
| 10262369 | 10038132 | 1.65 | 74 | 03 | null | 2016-06-09 | null | null | N | FLUOROURACIL + OXALIPLATIN | 101832191 |
| 10262452 | 10038133 | 1.8 | null | Palliative (P) | 2016-12-10 | 2016-12-26 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101752260 |
| 10262496 | 10038135 | 1.69 | 47.8 | null | null | 2019-12-22 | Gemcitabine weekly | 02 | N | GEMCITABINE | 100827274 |
| 10262512 | 10038136 | 1.8 | 50 | null | null | 2022-01-31 | null | null | null | CISPLATIN | 100804761 |
| 10262517 | 10038137 | 1.55 | 74.4 | Palliative (P) | null | 2017-04-19 | null | null | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101346884 |
| 10262577 | 10038138 | 1.78 | 114 | Curative (C) | null | 2019-11-04 | null | null | Y | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100236781 |
| 10262635 | 10038139 | 1.77 | 67.75 | null | null | 2018-06-07 | null | null | null | CISPLATIN | 100453208 |
| 10262637 | 10038140 | 1.65 | 59.7 | Adjuvant (A) | 2019-04-06 | 2019-04-08 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101298779 |
| 10262663 | 10038141 | 1.7 | 109 | null | null | 2016-07-19 | null | null | N | TRIAL UNSPECIFIED | 101389428 |
| 10262704 | 10038142 | 1.82 | 80.1 | Palliative (P) | null | 2018-12-29 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100967540 |